In March 2026 I announced the introduction of a new patient-centred medicines optimisation support framework which commenced on 1 June 2026.
This framework is designed to strengthen supports for medical card holders in vulnerable patient groups, including those with diagnosed cognitive impairment or dementia, intellectual disability, physical impairment or those patients at risk of medication misuse. These patients will be supported where appropriate with a range of tailored supports including:
• adjustments to facilitate use of original packaging.
• medication reminder systems.
• administration charts.
• instalment dispensing; and
• blister packs where clinically necessary.
Blister packs remain a last resort in line with the international evidence due to associated risks including reduced patient autonomy and potential safety concerns. Where clinically required, and deemed appropriate, blister packs will be provided free-of-charge to eligible medical card patients, in identified cohorts.
Medications for those living in residential care settings are managed in line with HIQA standards, through the residential service’s policies and procedures for medicines management. Pharmacists providing services to residential care settings should also refer to the relevant Pharmaceutical Society of Ireland guidance. Blister packs for medical card patients living in residential care settings will not be provided free of charge under this new Agreement.
